These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2967715)

  • 1. Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children.
    Turpeinen M
    Br J Dermatol; 1988 Apr; 118(4):517-22. PubMed ID: 2967715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease.
    Turpeinen M; Salo OP; Leisti S
    Br J Dermatol; 1986 Oct; 115(4):475-84. PubMed ID: 2946314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children.
    Turpeinen M; Lehtokoski-Lehtiniemi E; Leisti S; Salo OP
    Pediatr Dermatol; 1988 Nov; 5(4):276-9. PubMed ID: 2976496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous absorption of hydrocortisone during exacerbation and remission of atopic dermatitis in adults.
    Turpeinen M; Mashkilleyson N; Björkstén F; Salo OP
    Acta Derm Venereol; 1988; 68(4):331-5. PubMed ID: 2459879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of hydrocortisone from the skin reservoir in atopic dermatitis.
    Turpeinen M
    Br J Dermatol; 1991 Apr; 124(4):358-60. PubMed ID: 2025556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis.
    Aalto-Korte K; Turpeinen M
    Br J Dermatol; 1995 Aug; 133(2):259-63. PubMed ID: 7547394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical response to adrenocorticotropic hormone in relation to duration of topical therapy and percutaneous absorption of hydrocortisone in children with dermatitis.
    Turpeinen M
    Eur J Pediatr; 1989 Aug; 148(8):729-31. PubMed ID: 2792121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of skin barrier function during treatment of atopic dermatitis.
    Aalto-Korte K
    J Am Acad Dermatol; 1995 Dec; 33(6):969-72. PubMed ID: 7490367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical function in patients with severe atopic dermatitis.
    Matsuda K; Katsunuma T; Iikura Y; Kato H; Saito H; Akasawa A
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):35-9. PubMed ID: 10923602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transepidermal water loss and absorption of hydrocortisone in widespread dermatitis.
    Aalto-Korte K; Turpeinen M
    Br J Dermatol; 1993 Jun; 128(6):633-5. PubMed ID: 8338747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis.
    Ellison JA; Patel L; Ray DW; David TJ; Clayton PE
    Pediatrics; 2000 Apr; 105(4 Pt 1):794-9. PubMed ID: 10742322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal function following topical steroid treatment in children with atopic dermatitis.
    Patel L; Clayton PE; Addison GM; Price DA; David TJ
    Br J Dermatol; 1995 Jun; 132(6):950-5. PubMed ID: 7662574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transepidermal water loss predicts systemic absorption of topical hydrocortisone in atopic dermatitis.
    Aalto-Korte K; Turpeinen M
    Br J Dermatol; 1996 Sep; 135(3):497-8. PubMed ID: 8949461
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
    Abramovits W; Oquendo M
    Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluocinolone acetonide 0.01% in peanut oil: safety and efficacy data in the treatment of childhood atopic dermatitis in infants as young as 3 months of age.
    Dohil MA; Alvarez-Connelly E; Eichenfield LF
    Pediatr Dermatol; 2009; 26(3):262-8. PubMed ID: 19706085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
    Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of Clinitar versus hydrocortisone cream in the treatment of atopic eczema.
    Munkvad M
    Br J Dermatol; 1989 Dec; 121(6):763-6. PubMed ID: 2611126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical corticosteroid therapy for children: alclometasone dipropionate cream 0.05%.
    Crespi HG
    Clin Ther; 1986; 8(2):203-10. PubMed ID: 2938740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying systemic absorption of topical hydrocortisone in erythroderma.
    Aalto-Korte K; Turpeinen M
    Br J Dermatol; 1995 Sep; 133(3):403-8. PubMed ID: 8546995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.